COVID-19 drugs: a critical review of physicochemical properties and removal methods in water
Z.H. Chen,
No information about this author
Jiani Xu,
No information about this author
Cong Li
No information about this author
et al.
Journal of environmental chemical engineering,
Journal Year:
2025,
Volume and Issue:
13(1), P. 115310 - 115310
Published: Jan. 5, 2025
Language: Английский
Analysis of Structures of SARS-CoV-2 Papain-like Protease Bound with Ligands Unveils Structural Features for Inhibiting the Enzyme
Ann Varghese,
No information about this author
Jie Liu,
No information about this author
Bailang Liu
No information about this author
et al.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(3), P. 491 - 491
Published: Jan. 23, 2025
The
COVID-19
pandemic,
driven
by
the
novel
coronavirus
SARS-CoV-2,
has
drastically
reshaped
global
health
and
socioeconomic
landscapes.
papain-like
protease
(PLpro)
plays
a
critical
role
in
viral
polyprotein
cleavage
immune
evasion,
making
it
prime
target
for
therapeutic
intervention.
Numerous
compounds
have
been
identified
as
inhibitors
of
SARS-CoV-2
PLpro,
with
many
characterized
through
crystallographic
studies.
To
date,
over
70
three-dimensional
(3D)
structures
PLpro
complexed
ligands
deposited
Protein
Data
Bank,
offering
valuable
insight
into
ligand-binding
features
that
could
aid
discovery
development
effective
treatments
targeting
PLpro.
In
this
study,
we
reviewed
analyzed
these
3D
structures,
focusing
on
key
residues
involved
ligand
interactions.
Our
analysis
revealed
most
bind
to
PLpro’s
substrate
recognition
sites
S3/S4
SUb2.
While
are
highly
attractive
extensively
explored,
other
potential
binding
regions,
such
SUb1
Zn(II)
domain,
less
explored
may
hold
untapped
future
drug
development.
structural
provides
insights
molecular
accelerate
therapeutics
essential
enzyme.
Language: Английский
Inhibition of hostN-myristoylation compromises the infectivity of SARS-CoV-2 due to Golgi-bypassing egress from lysosomes and endoplasmic reticulum
Saber H. Saber,
No information about this author
Mohammed R. Shaker,
No information about this author
Julian Sng
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: March 3, 2023
Abstract
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
caused
the
disease
2019
(COVID-19)
pandemic,
remains
a
global
health
concern
despite
vaccines,
neutralizing
antibodies,
and
antiviral
drugs.
Emerging
mutations
can
reduce
effectiveness
of
these
treatments,
suggesting
that
targeting
host
cell
factors
may
be
valuable
alternative.
N
-myristoyltransferases
(NMT)
are
essential
enzymes
for
protein
-myristoylation,
affecting
stability,
interaction,
localization,
function
numerous
proteins.
We
demonstrate
selective
inhibition
NMT
decreases
SARS-CoV-2
infection
by
90%
in
human
lung
primary
nasal
epithelial
cells,
choroid
plexus-cortical
neuron
organoids.
does
not
affect
viral
entry,
replication
or
release,
but
impairs
maturation
incorporation
envelope
proteins
into
newly
assembled
virions,
leading
to
compromised
infectivity
released
virions.
The
triggers
Golgi-bypassing
pathway
progeny
virion
egress,
occurs
through
endoplasmic
reticulum
lysosomal
intermediates.
Language: Английский